Eylea aflibercept ophthalmic solution regulatory update

Regeneron and Bayer said Japan approved Eylea aflibercept ophthalmic solution to treat macular edema secondary to branch retinal vein occlusion (RVO). The human fusion protein that binds all forms of ...